BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative oncology biotechnology companies. The Board also represents leading investors and has substantial commercial experience to navigate the development of the Company.
Dr. Stener Kvinnsland
Stener Kvinnsland has more than 30 years of experience in…Read More
Dr. Pamela A. Trail
Pamela A. Trail is CSO of Molecular Partners AG. Previously…Read More
Mr. Grunde Eriksen
Grunde Eriksen is the founder and CEO of Altitude Capital…Read More